Home - Products - Others - Other Targets - cAMP Dependent Protein Kinase Substrate

cAMP Dependent Protein Kinase Substrate

CAS No. 65189-70-0

cAMP Dependent Protein Kinase Substrate( ——— )

Catalog No. M40337 CAS No. 65189-70-0

H1-7 (histone H1 phosphorylation site), PKA Substrate, a synthetic polypeptide, can be used as PKA substrate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    cAMP Dependent Protein Kinase Substrate
  • Note
    Research use only, not for human use.
  • Brief Description
    H1-7 (histone H1 phosphorylation site), PKA Substrate, a synthetic polypeptide, can be used as PKA substrate.
  • Description
    H1-7 (histone H1 phosphorylation site), PKA Substrate, a synthetic polypeptide, can be used as PKA substrate.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    65189-70-0
  • Formula Weight
    770.9
  • Molecular Formula
    C31H58N14O9
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pomerantz AH, et, al. Studies on the mechanism of phosphorylation of synthetic polypeptides by a calf thymus cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4261-5. ?
molnova catalog
related products
  • Acetyl-(Tyr1,D-Phe2)...

    Acetyl-(Tyr1,D-Phe2)-GRF (1-29) amide (human)

  • Ibuprofen diethylami...

    Ibuprofen diethylaminoethyl ester (BF DEAE) has anti-inflammatory activity, acts as a local anaesthetic and can be used in the study of neurological disorders.

  • AMRI-59

    AMRI-59 is a potent inhibitor of PrxI with anti-tumor activity.